Evidence map›Paper›PMID 31025282›Full record

ReviewEnvironmental science and pollution research international2020

Nanoinformatics and biomolecular nanomodeling: a novel move en route for effective cancer treatment.

Neha Sharma, Mala Sharma, Qazi M Sajid Jamal, Mohammad A Kamal, Salman Akhtar

Abstract readReview
PubMed Publisher
In one paragraph

Review in Environmental science and pollution research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Advances in nanotechnology, nanopollution, nanotoxicology, and nanomedicine.Environmental science and pollution research international · 2020
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Neha SharmaDepartment of Bioengineering, Faculty of Engineering, Integral University, Lucknow, UP, 226026, India.
Mala SharmaAdvanced Center of Bioengineering and Bioinformatics, Integral Information and Research Centre, Integral University, Lucknow, UP, 226026, India.
Qazi M Sajid JamalDepartment of Health Informatics, College of Public Health and Health Informatics, Qassim University, King Abdulaziz Rd, Al Bukayriyah, 52741, Al Qassim, Saudi Arabia.
Mohammad A KamalKing Fahad Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
Salman AkhtarDepartment of Bioengineering, Faculty of Engineering, Integral University, Lucknow, UP, 226026, India. salmanakhtar18@gmail.com.ORCID http://orcid.org/0000-0003-2921-3950

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Empowering role of nanoinformatics in design and elucidation of nanoparticles for effective cancer treatment has made this field a fascinating area for researchers, inspiring them to enhance up the quality and efficacy of existing anticancer medicines. Theoretical and computational modeling is being seen as a forefront solution for problems related to surface chemistry, optimized geometry, or other properties in nanoparticle designing and drug delivery. The current review aims to acquaint with the insight story of the incubation of in silico tools and techniques in nanotechnology to develop better anticancer nanomedicines. The review also recapitulates the assets and liabilities of this field and present an outline of existing inventiveness and endeavors of nanoinformatics. We propose how nanoinformatics could hasten up the advancements in anticancer nanomedicines through use of computational tools, nanoparticles repositories & various modeling and simulation methods.

Indexed as

NanoparticlesNeoplasmsComputer SimulationHumansNanomedicineNanotechnologyAnticancerNanodrug deliveryNanoinformaticsNanomedicinesNanoparticle modelingNanosimulations

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.